Quidel, a provider of rapid diagnostic testing solutions and cell-based virology assays, received the CE mark for its Quidel Molecular Direct C. difficile Tox A/B assay for detection of toxigenic Clostridium difficile (C. difficile) bacterial DNA.

The Direct C. difficile Tox A/B assay kit features an extraction-free, three-step sample preparation process which requires no heat-step, no timed step and no centrifugation, as an added benefit.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The direct-to-amplification procedure enables the assay to generate results in less than 60 minutes, Quidel said. The assay is part of the company’s molecular diagnostics product line, which includes PCR reagent kits for use by molecular diagnostic laboratories with its existing thermocyclers.

Quidel chief scientific officer Timothy Stenzel said a recent study by the Centers for Disease Control and Prevention suggested nucleic acid amplification tests can be as much as twice as sensitive as enzyme immunoassays.

"Preventing transmission of C. difficile by early and accurate detection in order to isolate and properly treat patients with Clostridium difficile infection is essential to reducing the overall disease burden," Stenzel added.

See Also:

Quidel Corporation president and chief executive officer Douglas Bryant said the PCR assay, along with the company’s CE marked AmpliVue assay and cell culture-based toxin detection system for C. difficile will help meet the testing volume and resource needs for many different types of laboratories.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

"In receiving CE mark for our second molecular assay for C. difficile, we have expanded our molecular offering beyond respiratory infections," Bryant added.

According to the company, the Direct C. difficile Tox A/B assay is commercially available in Europe.